Moreover, miR-221 suppression or the restoration of PTEN expression reversed the malignant phenotypes of HER2+ BC, indicating the critical role of miRNAs in regulating the progression of HER2+ breast cancer[118]. The gene discussed is ERBB2; the disease is breast carcinoma.